Transaction #10864 · Form 4 · 0001213900-25-113113
Starling Oncology, Inc. · Other acquisition · Common Stock
Starling Oncology, Inc. · Transacted November 18, 2025 · Filed November 20, 2025
What does this filing report?
An SEC Form 4 filing for Starling Oncology, Inc. records an other acquisition involving Common Stock on November 18, 2025. The reported quantity was 11,818. The filing date is November 20, 2025. This is one transaction record; amounts are not allocated among any joint reporting owners.
The acquisition category describes how securities were received. It does not by itself establish a cash purchase of common stock. Read the transaction code definitionsand the original filing before interpreting the amounts.
Transaction details
- Company
- Starling Oncology, Inc.
- Company CIK
- 0001799191
- Security type
- Non-derivative
- Acquisition type
- Other acquisition · Code J
- Quantity acquired
- 11,818
- Reported price
- Not reported · See footnotes
- Reference value
- Not reported
- Currency
- Currency not specified
- Ownership
- Direct
- Holdings after transaction
- 7,944,207
- Ownership description
- Not reported
- SEC acceptance time
- Nov 20, 2025, 4:02 PM EST
- 10b5-1 indication
- Not indicated
Reference value is reported quantity × reported price. It is not a confirmed cash payment or an estimate of a derivative's economic value. A missing currency is not assumed to be USD.
Reporting owners
- M33 Growth I L.P. ↗
Director
CIK 0001718621
- TOI M, LLC ↗
Director
CIK 0001892968
- M33 Growth I GP LLC ↗
Director
CIK 0001894303
These are the reporting owners named in the filing. Quantities and amounts are not allocated among co-reporters. Roles reflect this filing, not a current profile.
Company listings
This transaction is not mapped to a specific company listing.
Filing footnotes & remarks
- F1
- On November 18, 2025, TOI M, LLC made a distribution in-kind of 590,892 shares of the Issuer's common stock to its members, including 11,818 shares distributed to M33 Growth I L.P. ("M33 LP"). Also on November 18, 2025, M33 LP made a distribution-in-kind of 2,500,000 shares of the Issuer's common stock to its limited partners.
- F2
- These securities were held by TOI M, LLC.
- F3
- M33 Growth I GP LLC is the general partner of M33 LP and may be deemed to beneficially own the shares held by M33 LP but disclaims beneficial ownership of these shares except to the extent of its pecuniary interest therein.
Footnotes are reproduced as plain text from the current source filing. For the full context, read the original SEC filing.
This record was updated Eastern Time. This is the stored record update time, not the transaction date. Report a correction.